Stay updated on Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Sign up to get notified when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.

Latest updates to the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.4.3 as an addition and Revision: v3.4.2 as removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedNew revision tag v3.4.2 was added to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding/status notice regarding NIH operations and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a glossary toggle (Show glossary) and new labels for QC status and software revision (Last Update Submitted that Met QC Criteria, Revision: v3.4.0). Removed or renamed older items such as Last Update Submitted that met QC Criteria and No FEAR Act data.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check83 days agoChange DetectedLocations have been added and organized under a unified Locations section, listing sites in Baden-Wurttemberg, Bavaria, Hesse, and Saxony. The previous state-specific location sections were removed, and the page revision updated to v3.3.3.SummaryDifference0.6%

Stay in the know with updates to Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.